Resmed Inc. buy Mizuho
Start price
31.10.23
/
50%
€132.65
Target price
31.10.24
€150.86
Performance (%)
69.02%
End price
01.11.24
€224.20
Summary
This prediction ended on 01.11.24 with a price of €224.20. With a performance of 69.02% the BUY prediction by Mizuho was a big success. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.82 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -1.236% | -1.236% | -26.675% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Mizuho from $180.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten